comprehensive -WSS

comprehensive

author：entertainment 2025-09-09 19:28:43 - browse：1495

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Telehealth for opioid use disorder is lifesaving

focus

WSS

Telehealth for opioid use disorder is lifesaving

FDA panel endorses Alnylam’s heart drug — after picking it apart

Telehealth for opioid use disorder is lifesaving

PEPFAR is under serious threat — and so is global health

Generate Biomedicines machine learning biotech raises $273M

How to make the FDA’s new prescription one

Wikipedia

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Medicare proposal to cover medical devices draws a mixed reaction

The Readout: Lenmeldy, GLP

Supreme Court strikes down use of affirmative action

Diverse clinical trials: Why aren’t we there yet?

After affirmative action ruling, medical educators look to 'holistic review'

Primary care physicians play key roles in Alzheimer's management

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

How one medical school became remarkably diverse

White House touts steps to stem shortages of cancer treatments

hotspot

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Food makers to regulators: Ultra

Diverse clinical trials: Why aren’t we there yet?

How housing is health care on Long Island

Abortion pill Supreme Court ruling could impact entire drug industry

Scientists boost immune system in aging mice by making it youthful

focus

focus

focus

hotspot